search
Back to results

Evaluation of EarlySense Home Care Tele-monitoring Device

Primary Purpose

Myocardial Infarction, Cardiac Surgery

Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Home Monitoring
Sponsored by
Sheba Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Myocardial Infarction focused on measuring telemonitoring

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients who resided in Shelev following a cardiac event (cardiac surgery, myocardial infarction, pacemaker implantation or other cardiac interventions )
  2. Age ≥ 21 years
  3. Any patient hosted in Shelev with geographically resident within 50 Km from Sheba Medical Center
  4. Patients agrees to sign the consent form and able to comply with study protocol.
  5. Sleeps on a mattress

Exclusion Criteria:

  1. Planned readmission within 30 days of discharge from hospital
  2. Discharge to hospice care.
  3. Patients with cognitive disabilities
  4. Patient's major treating hospital is not the Sheba Medical Center

Sites / Locations

  • SheLev, Sheba Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Home monitoring

Arm Description

Home monitoring via the EarlySense non-invasive nocturnal monitoring system. Movement, heart rate and respiratory rates will be monitored while subject is in his bed. The trends of monitored values will be daily reported to a central repository. No intervention will be attempted and care will be coordinated by the family physician and treating cardiologist as usual.

Outcomes

Primary Outcome Measures

Diagnositic Utility
Positive percent agreement between the EarlySense device and clinical events as adjudicated by health-care personal

Secondary Outcome Measures

System Acceptance
Assess the acceptability of the EarlySense Home care device by clinicians and by patients and their families in their own home as determined by a provided questioner.

Full Information

First Posted
December 7, 2014
Last Updated
December 11, 2014
Sponsor
Sheba Medical Center
Collaborators
EarlySense Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT02318004
Brief Title
Evaluation of EarlySense Home Care Tele-monitoring Device
Official Title
Study Protocol for Evaluation of EarlySense Home Care Tele-monitoring Device - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion For Early Detection of Deterioration For Cardiac Patients at Home
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Unknown status
Study Start Date
December 2014 (undefined)
Primary Completion Date
December 2015 (Anticipated)
Study Completion Date
February 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sheba Medical Center
Collaborators
EarlySense Ltd.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The aims of the present study are to evaluate the information obtained by the EarlySenese monitoring system and examine correlation of the obtained data and clinical events.
Detailed Description
The EarlySense Home Care System developed by EarlySense, Ltd., is a contact-less tele-monitoring system. The system is intended for continuous monitoring of patients' respiration rate, heart rate and patient's motion. The system, which monitors the patient while in bed, consists of a piezoelectric sensor that produces an electrical signal in response to physiological stimulation, and a microprocessor control unit that analyzes the recorded signal and identifies respiratory and heart rates and patient motion, while patient is in bed,. In addition, the system indicates patient's in or out of bed status. The system also provides alerts if either of the physiological parameters cross predefined threshold settings (e.g., high/ low heart rate or respiratory rate, or motion or time in bed). The system saves patient's parameters and then flags the patients, as those to have changes in their vital signs and motion, or those that do not have noteworthy changes during recent hours of monitoring. Flagging of the patients are based on changes detected in patients' baseline vital signs (heart and respiratory rates and patterns) and well as recognition of changes in patients motion and in and out of bed status in comparison to set thresholds. The aim of this study is to evaluate relevance of the information (vital sign trends, alerts and flags) as provided by the EarlySense Home Care Tele-monitoring system to medical staff in Sheba Medical Center's Heart Rehabilitation Institute (Shelev) in order proactively monitor patients at home. The correlation between the EarlySense system alerts and flags to patient deterioration and hospital readmission will be studied.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Infarction, Cardiac Surgery
Keywords
telemonitoring

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Home monitoring
Arm Type
Experimental
Arm Description
Home monitoring via the EarlySense non-invasive nocturnal monitoring system. Movement, heart rate and respiratory rates will be monitored while subject is in his bed. The trends of monitored values will be daily reported to a central repository. No intervention will be attempted and care will be coordinated by the family physician and treating cardiologist as usual.
Intervention Type
Other
Intervention Name(s)
Home Monitoring
Intervention Description
Non invasive nocturnal monitoring of heart and respiratory rate and subjects movement out of bed.
Primary Outcome Measure Information:
Title
Diagnositic Utility
Description
Positive percent agreement between the EarlySense device and clinical events as adjudicated by health-care personal
Time Frame
30 days following enrollment
Secondary Outcome Measure Information:
Title
System Acceptance
Description
Assess the acceptability of the EarlySense Home care device by clinicians and by patients and their families in their own home as determined by a provided questioner.
Time Frame
30 days following enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who resided in Shelev following a cardiac event (cardiac surgery, myocardial infarction, pacemaker implantation or other cardiac interventions ) Age ≥ 21 years Any patient hosted in Shelev with geographically resident within 50 Km from Sheba Medical Center Patients agrees to sign the consent form and able to comply with study protocol. Sleeps on a mattress Exclusion Criteria: Planned readmission within 30 days of discharge from hospital Discharge to hospice care. Patients with cognitive disabilities Patient's major treating hospital is not the Sheba Medical Center
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Robert Klempfner, MD
Email
klempfner@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Meirav Moreno, Msc
Email
Merav.Moreno@sheba.health.gov.il
Facility Information:
Facility Name
SheLev, Sheba Medical Center
City
Ramat Gan
ZIP/Postal Code
52621
Country
Israel
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Robert Klempfner, MD
Email
klempfner@gmail.com
First Name & Middle Initial & Last Name & Degree
David Rott, MD
First Name & Middle Initial & Last Name & Degree
Robert Klempfner, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
22865462
Citation
Zimlichman E, Szyper-Kravitz M, Shinar Z, Klap T, Levkovich S, Unterman A, Rozenblum R, Rothschild JM, Amital H, Shoenfeld Y. Early recognition of acutely deteriorating patients in non-intensive care units: assessment of an innovative monitoring technology. J Hosp Med. 2012 Oct;7(8):628-33. doi: 10.1002/jhm.1963. Epub 2012 Aug 3.
Results Reference
background
PubMed Identifier
21926639
Citation
Zimlichman E, Shinar Z, Rozenblum R, Levkovich S, Skiano S, Szyper-Kravitz M, Altman A, Amital H, Shoenfeld Y. Using continuous motion monitoring technology to determine patient's risk for development of pressure ulcers. J Patient Saf. 2011 Dec;7(4):181-4. doi: 10.1097/PTS.0b013e318230e6ef.
Results Reference
background

Learn more about this trial

Evaluation of EarlySense Home Care Tele-monitoring Device

We'll reach out to this number within 24 hrs